{
    "clinical_study": {
        "@rank": "109415", 
        "arm_group": [
            {
                "arm_group_label": "Active rTMS", 
                "arm_group_type": "Active Comparator", 
                "description": "rTMS over Supplementary Motor Area, 1hz, no pauses, 20 minutes per sessions. Total: 20 sessions."
            }, 
            {
                "arm_group_label": "Sham", 
                "arm_group_type": "Sham Comparator", 
                "description": "Sham stimulation, 20 minutes per session, total 20 sessions"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a study to evaluate the efficacy of rTMS for relief of obsessive-compulsive symptoms\n      in patients with schizophrenia."
        }, 
        "brief_title": "Repetitive Transcranial Magnetic Stimulation (rTMS) as an add-on Treatment for Resistant Obsessive-compulsive Symptoms in Patients With Schizophrenia", 
        "condition": [
            "Schizophrenia", 
            "Obsessive-Compulsive Symptoms"
        ], 
        "condition_browse": {
            "mesh_term": "Schizophrenia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of Schizophrenia (DSM-IV-TR)\n\n          -  YBOCS > 16\n\n        Exclusion Criteria:\n\n          -  Mental Retardation\n\n          -  Substance abuse\n\n          -  Any contraindication to rTMS"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02105064", 
            "org_study_id": "rTMS Esquizo-TOC"
        }, 
        "intervention": [
            {
                "arm_group_label": "Active rTMS", 
                "description": "rTMS over supplementary motor area, 1hz, no pauses, 20 minutes/sessions, 5 sessions/week, 4 weeks. Total 20 sessions.", 
                "intervention_name": "Active rTMS", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Sham", 
                "description": "Sham rTMS, without brain stimulation", 
                "intervention_name": "SHAM rTMS", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 2, 2014", 
        "location": {
            "contact": {
                "email": "vautomf@yahoo.com.br", 
                "last_name": "Vauto A Mendes-Filho, Psychiatrist", 
                "phone": "+5515182008430"
            }, 
            "facility": {
                "address": {
                    "city": "Porto Alegre", 
                    "country": "Brazil", 
                    "state": "Rio Grande do Sul", 
                    "zip": "90035-903"
                }, 
                "name": "Hospital de Cl\u00ednicas de Porto Alegre"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "vautomf@yahoo.com.br", 
            "last_name": "Vauto A Mendes-Filho, Psychiatrist", 
            "phone": "+555182008430"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Brazil: National Committee of Ethics in Research"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change of Obsessive Compulsive symptoms (using Yale-Brown Obsessive Compulsive Scale - Y-BOCS)", 
            "safety_issue": "No", 
            "time_frame": "Baseline, after 20 rTMS sessions (an expected average of 4 weeks), and 4 weeks after end of treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02105064"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change of Psychotic Symptoms (using Brief Psychiatric Rating Scale - BPRS)", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline, after 20 rTMS sessions (an expected average of 4 weeks), and 4 weeks after end of treatment"
            }, 
            {
                "measure": "Change of Brain-Derived Neurotrophic Factor (BDNF)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, after 20 rTMS sessions (an expected average of 4 weeks), and 4 weeks after end of treatment"
            }
        ], 
        "source": "Hospital de Clinicas de Porto Alegre", 
        "sponsors": {
            "collaborator": {
                "agency": "Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Hospital de Clinicas de Porto Alegre", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}